{"gene":"HRH1","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1994,"finding":"HRH1 (human RNA helicase 1) was identified as a human homolog of yeast Prp22, containing DEAH-box helicase motifs. HRH1 expression in a S. cerevisiae prp22 mutant partially rescued its temperature-sensitive phenotype. HRH1 contains an RS domain absent in Prp22, and this RS domain mediates interaction with SR protein family members both in vitro and in the yeast two-hybrid system, suggesting HRH1 is targeted to the spliceosome through this interaction.","method":"PCR cloning, yeast complementation assay, in vitro interaction assay, yeast two-hybrid","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including functional complementation and direct interaction assays","pmids":["7935475"],"is_preprint":false},{"year":1996,"finding":"HRH1 facilitates nuclear export of spliced mRNA by releasing it from the spliceosome. Dominant-negative HRH1++ mutants (dn-HRH1) stall on the spliceosome and prevent release of spliced RNA from the spliceosome in vitro. Expression of dn-HRH1 in mammalian cells inhibits splicing and causes nuclear export of unspliced pre-mRNA due to spliceosome recycling defects. The RS domain of HRH1 confers a nuclear localization signal and facilitates interaction with the spliceosome.","method":"Dominant-negative mutant expression, in vitro spliceosome release assay, mammalian cell transfection","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — dominant-negative in vitro and in vivo assays with defined molecular phenotype, replicated across systems","pmids":["8608946"],"is_preprint":false},{"year":1993,"finding":"The human histamine H1 receptor (HRH1/H1R) was cloned from a human genomic library; the 487-amino acid protein is a G-protein-coupled receptor. When expressed in COS-7 cells, it shows saturable binding of [3H]pyrilamine (KD ~1.2 nM) and mediates histamine-induced inositol phosphate formation that is inhibitable by pyrilamine, demonstrating coupling to the Gq/phospholipase C pathway.","method":"Genomic cloning, heterologous expression in COS-7 cells, radioligand binding assay, inositol phosphate formation assay","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — reconstitution of receptor in heterologous system with functional assays confirming Gq coupling","pmids":["8280179"],"is_preprint":false},{"year":1994,"finding":"The human histamine H1 receptor gene is intron-lacking, encodes a 487-amino acid protein with GTP-binding protein-coupled receptor characteristics, and is mapped to chromosome 3p25 by fluorescence in situ hybridization. Northern blot analysis revealed tissue-specific expression with two mRNA species (3.0 and 3.5 kb) in peripheral tissues and only the 3.5-kb species in brain.","method":"Genomic cloning, Northern blot, FISH chromosomal mapping","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 2 — direct experimental chromosomal mapping and tissue expression confirmed by multiple methods","pmids":["8003029"],"is_preprint":false},{"year":2004,"finding":"GRK2 is the principal kinase mediating H1 histamine receptor (H1HR) desensitization in HEK293 cells. GRK2 overexpression promotes H1HR phosphorylation and completely inhibits inositol phosphate production. GRK2 regulates H1HR signaling through dual mechanisms: its kinase activity and its RGS function for Gαq/11. siRNA knockdown of endogenous GRK2 significantly increased histamine-promoted calcium flux, confirming endogenous GRK2 role. GRK5 had no significant effect.","method":"Overexpression of wild-type and mutant GRKs in HEK293 cells, phosphorylation assay, inositol phosphate assay, siRNA knockdown, calcium flux assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including mutagenesis and siRNA knockdown with defined molecular mechanism","pmids":["15542600"],"is_preprint":false},{"year":2005,"finding":"Using site-directed mutagenesis and molecular modeling, Ser3.36 and Asn7.45 were identified as key residues linking histamine binding to receptor activation in the human histamine H1 receptor. Ser3.36 acts as a rotamer toggle switch that upon agonist binding initiates receptor activation through Asn7.45, involving conformational changes in helices 6 and 7.","method":"Site-directed mutagenesis, molecular modeling","journal":"Nature chemical biology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis with functional validation defining activation mechanism","pmids":["16408006"],"is_preprint":false},{"year":2011,"finding":"Crystal structure of the human histamine H1 receptor in complex with the first-generation antagonist doxepin was determined. Doxepin sits deep in the ligand-binding pocket and directly interacts with Trp428(6.48), a key residue in GPCR activation. The pocket has mostly hydrophobic character explaining low selectivity of first-generation compounds. Second-generation antagonists interact with Lys191(5.39) and/or Lys179(ECL2) in an anion-binding region not conserved in other aminergic receptors, explaining their selectivity.","method":"X-ray crystallography, molecular docking","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with docking analysis revealing molecular basis of ligand selectivity","pmids":["21697825"],"is_preprint":false},{"year":2005,"finding":"HRH1 (histamine H1 receptor) activation in MA-10 murine and purified rat Leydig cells mediates inhibition of steroid synthesis. HRH1 activation increases inositol phosphate production, consistent with coupling to Gq protein and phospholipase C, while HRH2 activation stimulates steroidogenesis via adenylate cyclase/Gs. Selective agonists and antagonists confirmed these distinct receptor-pathway couplings.","method":"Pharmacological assay with selective agonists/antagonists, inositol phosphate assay, cAMP assay in Leydig cells","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological dissection with selective ligands, single study","pmids":["15917347"],"is_preprint":false},{"year":2016,"finding":"HRH1-mediated sensitization of TRPV1 is involved in visceral hypersensitivity in irritable bowel syndrome. Supernatants from IBS rectal biopsies sensitized TRPV1 in mouse dorsal root ganglion neurons via HRH1; histamine and imidazole acetaldehyde reproduced this effect. Pyrilamine (HRH1 antagonist) blocked histamine-induced TRPV1 sensitization. The HRH1 antagonist ebastine reduced visceral hypersensitivity in a randomized placebo-controlled clinical trial.","method":"Live calcium imaging of submucosal neurons, mouse DRG neuron sensitization assay, pharmacological blockade, randomized controlled trial","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal experimental approaches plus clinical validation; replicated across systems","pmids":["26752109"],"is_preprint":false},{"year":2021,"finding":"Cryo-EM structure of the human histamine H1 receptor in complex with Gq protein in active conformation was determined. Histamine activates the receptor by interacting with key residues in TM3 and TM6, squashing the binding pocket on the extracellular side and opening a cavity on the intracellular side for Gq engagement. ICL2 of H1R interacts with the αN-β junction of Gq/11 protein.","method":"Cryo-electron microscopy, NanoBiT tethering strategy","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — cryo-EM structure revealing activation mechanism and Gq coupling interface","pmids":["33828102"],"is_preprint":false},{"year":2018,"finding":"Wild-type HRH1 synthesized in a wheat germ cell-free system with glycerosomes exhibited saturable binding to [3H]pyrilamine (Kd = 9.76 nM). A D107A mutant HRH1 (Asp107 replaced by Ala) showed markedly reduced and non-saturable binding to the H1 antagonist, confirming that Asp107 is critical for ligand binding.","method":"Cell-free protein synthesis, radioligand binding assay, mutant receptor analysis","journal":"Frontiers in pharmacology","confidence":"Medium","confidence_rationale":"Tier 1 — reconstitution with mutagenesis confirming critical residue, single study","pmids":["29467651"],"is_preprint":false},{"year":2025,"finding":"HRH1 activates both Gαq and Gαi heterotrimers as shown by mini G protein recruitment and Gα activation assays in MDA-MB-231 cells. Pertussis toxin (PTx) disrupts histamine-induced Gαi binding to HRH1, causing a compensatory increase in Gαq binding and enhanced calcium signaling, which enables sensitive detection of PTx activity.","method":"Mini G protein recruitment assay, Gα activation assay, calcium signaling assay","journal":"Vaccine","confidence":"Medium","confidence_rationale":"Tier 2 — direct G protein coupling assays demonstrating dual Gαq/Gαi signaling, single study","pmids":["40158234"],"is_preprint":false},{"year":2017,"finding":"Systematic membrane yeast two-hybrid (MYTH) mapping identified protein-protein interaction partners for human HRH1 among 686 proteins connected through 987 unique interactions across 48 GPCRs, providing a resource for HRH1 signaling pathway analysis.","method":"Membrane yeast two-hybrid (MYTH) interactome mapping","journal":"Molecular systems biology","confidence":"Low","confidence_rationale":"Tier 3 — large-scale Y2H mapping, HRH1-specific interactions not individually validated","pmids":["28298427"],"is_preprint":false},{"year":2025,"finding":"In glioblastoma, genetic silencing of HRH1 inhibited GBM cell proliferation, migration, and invasion in vitro and in vivo. The HRH1-targeting monoclonal antibody and the specific antagonist terfenadine exerted anti-tumor effects mechanistically through PKC-dependent regulation of the RAF/MEK/ERK signaling pathway.","method":"siRNA/shRNA knockdown, xenograft model, pharmacological antagonism with terfenadine, signaling pathway analysis","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — genetic and pharmacological loss-of-function with identified downstream signaling mechanism, single study","pmids":["41125791"],"is_preprint":false},{"year":2024,"finding":"MSR1 overexpression in microglia increases phosphorylation of Akt via HRH1, expediting clearance of myelin debris through the PI3K/AKT pathway in ischemic white matter injury. MSR1-deficient mice showed exacerbated behavioral deficits and white matter injury after ischemic stroke.","method":"Gene knockout mouse model, overexpression studies, ischemic stroke model, pathway analysis","journal":"Neuroscience letters","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO and overexpression with defined signaling mechanism, single study","pmids":["39214333"],"is_preprint":false},{"year":2025,"finding":"Histamine promotes γδT17 cell differentiation through HRH1 in an Hrh1 receptor-dependent manner, with associated Wnt signaling pathway activation. RNA sequencing showed histamine exposure upregulated Hrh1 and activated the Wnt pathway, and in vitro experiments confirmed HRH1 dependence of this process.","method":"RNA sequencing, in vitro cell differentiation assay, pharmacological receptor blockade, pathway analysis","journal":"International immunopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — receptor-dependent functional assay with transcriptomic validation, single study","pmids":["41014774"],"is_preprint":false},{"year":2003,"finding":"Bphs/Hrh1 (histamine H1 receptor) controls susceptibility to pertussis toxin-induced histamine hypersensitivity and enhancement of antigen-specific delayed-type hypersensitivity responses. Using Bphs congenic and Hrh1 gene-disrupted mice, Hrh1 was shown to specifically mediate vasoactive amine sensitization to histamine but not serotonin, and did not influence lethal effects, leukocytosis, glucose regulation, or histamine-independent vascular permeability changes.","method":"Congenic mouse model, Hrh1 knockout mice, in vivo pertussis toxin challenge","journal":"Infection and immunity","confidence":"Medium","confidence_rationale":"Tier 2 — genetic loss-of-function with defined phenotypic specificity, single study","pmids":["12595443"],"is_preprint":false},{"year":2023,"finding":"In zebrafish, CRISPR/Cas9-generated hrh1-/- larvae showed transiently reduced tyrosine hydroxylase 1 (Th1)-positive (dopaminergic) cells and hypocretin-positive cells during early development, indicating HRH1 regulates dopaminergic and hypocretin/orexin systems. Adult hrh1-/- fish displayed impaired sociability and anxious-like behavior with downregulation of choline O-acetyltransferase a and LIM homeodomain transcription factor Islet1, suggesting HRH1 involvement in cholinergic and developmental gene regulation.","method":"CRISPR/Cas9 knockout, qPCR, in situ hybridization, immunocytochemistry, behavioral assays","journal":"Molecular neurobiology","confidence":"Medium","confidence_rationale":"Tier 2 — clean genetic KO with defined neurodevelopmental phenotypes and molecular markers, single study","pmids":["37474883"],"is_preprint":false},{"year":2025,"finding":"MRGPRX2 activation on mast cells by HBD-2 (secreted from endometriotic cells) triggers histamine release, which sensitizes dorsal root ganglion sensory neurons via HRH1/TRPV1 signaling to produce endometriosis pain. Desloratadine (HRH1 antagonist) reversed histamine-induced Ca2+ influx in DRG cells. Mrgprb2-deficient mice showed reduced hyperalgesia and lesion size.","method":"In vitro mast cell culture, Ca2+ imaging in DRG neurons, pharmacological antagonism, Mrgprb2 KO mouse model","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological and genetic loss-of-function establishing HRH1/TRPV1 signaling axis, single study","pmids":["40600649"],"is_preprint":false},{"year":2025,"finding":"Phenotypic screening and SCOPE computational enrichment identified HRH1 as a regulator of ER stress-induced exodosis (secretion of ER-resident proteins). This was validated by RNAi knockdown and pharmacological inhibition of HRH1, implicating HRH1-mediated calcium signaling (via Gq/IP3R pathway) in regulation of exodosis.","method":"High-throughput phenotypic screen, SCOPE pathway enrichment, RNAi knockdown, pharmacological inhibition","journal":"bioRxiv","confidence":"Low","confidence_rationale":"Tier 3 — computational enrichment with RNAi/pharmacological validation, preprint, single study","pmids":[],"is_preprint":true},{"year":2025,"finding":"In cutaneous squamous cell carcinoma with perineural invasion, tumor cells express elevated HRH1, and histamine from mast cells enhances tumor invasion into nerves via broad upregulation of matrix metalloproteinases (MMPs) through P38 activation, enabling collagen degradation in the nerve sheath. H1-antihistamines rescued this effect in PNI organoid models.","method":"Single-cell transcriptomics, PNI organoid model, pharmacological H1 blockade, MMP/P38 pathway analysis","journal":"bioRxiv","confidence":"Low","confidence_rationale":"Tier 3 — organoid model with pharmacological validation and mechanistic pathway identification, preprint","pmids":[],"is_preprint":true}],"current_model":"HRH1 encodes two distinct proteins: (1) the canonical histamine H1 receptor, a 487-amino acid GPCR (chromosome 3p25) that couples primarily to Gq/11 to activate phospholipase C/inositol phosphate signaling and Ca2+ release, is desensitized by GRK2 through both kinase and RGS mechanisms, and whose crystal and cryo-EM structures reveal that histamine binding at TM3/TM6 (via Ser3.36/Asn7.45 rotamer switching) squashes the extracellular pocket and opens the intracellular cavity for Gq engagement—mediating allergy, visceral hypersensitivity via TRPV1 sensitization, endometriosis pain, GBM proliferation via PKC/RAF/MEK/ERK, and immune cell functions; and (2) an unrelated nuclear RNA helicase (DEAH-box protein, human Prp22 homolog) that uses its helicase activity to release spliced mRNA from the spliceosome and whose RS domain confers nuclear localization and spliceosome targeting through interaction with SR proteins."},"narrative":{"teleology":[{"year":1993,"claim":"Cloning and heterologous expression of the human histamine H1 receptor established it as a Gq-coupled GPCR that mediates inositol phosphate formation, resolving the molecular identity of the pharmacologically defined H1 receptor.","evidence":"Genomic cloning with radioligand binding and IP formation assays in COS-7 cells","pmids":["8280179"],"confidence":"High","gaps":["Downstream effectors beyond PLC not characterized","No structural information on the receptor"]},{"year":1994,"claim":"Chromosomal mapping to 3p25 and demonstration of an intronless gene with tissue-specific mRNA isoforms defined the genomic architecture of HRH1.","evidence":"FISH mapping and Northern blot analysis","pmids":["8003029"],"confidence":"High","gaps":["Functional significance of two mRNA species unresolved","Promoter regulation not characterized"]},{"year":2004,"claim":"Identification of GRK2 as the principal desensitization kinase for HRH1, operating through both phosphorylation and an RGS-like mechanism toward Gαq/11, explained how H1 receptor signaling is terminated.","evidence":"GRK overexpression/mutagenesis, siRNA knockdown, and calcium flux assays in HEK293 cells","pmids":["15542600"],"confidence":"High","gaps":["Arrestin recruitment and internalization trafficking not defined","In vivo desensitization kinetics unknown"]},{"year":2005,"claim":"Mutagenesis of Ser3.36 and Asn7.45 revealed a rotamer toggle switch linking agonist binding to conformational activation, providing the first mechanistic model of H1R activation at atomic resolution.","evidence":"Site-directed mutagenesis with functional assays and molecular modeling","pmids":["16408006"],"confidence":"High","gaps":["No experimental structure available at that time","Contributions of other residues to activation not mapped"]},{"year":2011,"claim":"The crystal structure of H1R bound to doxepin revealed the molecular basis of first- versus second-generation antihistamine selectivity, showing that selective compounds exploit a non-conserved anion-binding region involving Lys191/Lys179.","evidence":"X-ray crystallography with molecular docking","pmids":["21697825"],"confidence":"High","gaps":["Active-state structure not yet available","Gq coupling interface not resolved"]},{"year":2016,"claim":"Demonstration that HRH1 sensitizes TRPV1 on sensory neurons extended the receptor's role beyond allergy into visceral pain pathophysiology, validated by clinical efficacy of the H1 antagonist ebastine in IBS.","evidence":"DRG neuron calcium imaging, pharmacological blockade, and randomized controlled trial","pmids":["26752109"],"confidence":"High","gaps":["Intracellular signaling intermediates linking HRH1 to TRPV1 sensitization not fully mapped","Long-term clinical efficacy data limited"]},{"year":2021,"claim":"The cryo-EM structure of the active H1R–Gq complex revealed that histamine compresses the extracellular pocket while opening an intracellular cavity, and that ICL2 contacts the αN-β junction of Gq, completing the structural picture of receptor activation and G protein engagement.","evidence":"Cryo-EM with NanoBiT tethering strategy","pmids":["33828102"],"confidence":"High","gaps":["Biased agonism and alternative G protein coupling structural basis not resolved","No structure of β-arrestin-bound H1R"]},{"year":2025,"claim":"Functional studies established that HRH1 couples to both Gαq and Gαi, with pertussis toxin-mediated disruption of Gαi causing compensatory enhancement of Gαq signaling, revealing dual G protein engagement.","evidence":"Mini G protein recruitment and Gα activation assays in MDA-MB-231 cells","pmids":["40158234"],"confidence":"Medium","gaps":["Physiological contexts where Gαi coupling predominates not defined","Structural basis for dual coupling unknown","Independent replication in other cell lines needed"]},{"year":2025,"claim":"In glioblastoma, HRH1 was shown to drive proliferation, migration, and invasion through PKC-dependent RAF/MEK/ERK activation, establishing oncogenic signaling downstream of H1R in brain tumors.","evidence":"siRNA/shRNA knockdown, xenograft models, and terfenadine antagonism with signaling pathway analysis","pmids":["41125791"],"confidence":"Medium","gaps":["Whether constitutive activity or autocrine histamine drives GBM signaling unclear","Patient-derived data on HRH1 expression and outcomes limited"]},{"year":2025,"claim":"HRH1/TRPV1 signaling was extended to endometriosis pain, with mast cell-derived histamine sensitizing DRG neurons through HRH1, broadening the receptor's pain-related roles beyond IBS.","evidence":"Ca2+ imaging in DRG neurons, desloratadine blockade, Mrgprb2 KO mouse model","pmids":["40600649"],"confidence":"Medium","gaps":["Downstream kinase pathway from HRH1 to TRPV1 phosphorylation not identified","Clinical translation to endometriosis patients not tested"]},{"year":null,"claim":"Key unresolved questions include the structural basis of biased agonism and β-arrestin engagement at H1R, the full spectrum of tissues where Gαi coupling is physiologically relevant, and whether constitutive H1R activity contributes to tumor signaling independently of histamine.","evidence":"","pmids":[],"confidence":"Low","gaps":["No β-arrestin-bound H1R structure","In vivo biased signaling not characterized","Role of constitutive activity in cancer not delineated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[2,5,9]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[4,8,15]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,6,9]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,4,5,9,11]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[15,16]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[8,17,18]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[13]}],"complexes":[],"partners":["GRK2","GNAQ","GNA11","GNAI1","TRPV1"],"other_free_text":[]},"mechanistic_narrative":"The histamine H1 receptor (HRH1) is a Gq/11-coupled GPCR that activates phospholipase C to generate inositol phosphates and mobilize intracellular calcium, mediating allergic, inflammatory, and neuromodulatory responses to histamine [PMID:8280179, PMID:15542600]. Crystal and cryo-EM structures reveal that histamine binding deep in the transmembrane pocket engages a Ser3.36/Asn7.45 rotamer switch that compresses the extracellular face and opens the intracellular cavity for Gq engagement via the ICL2–Gαq αN-β junction interface [PMID:21697825, PMID:33828102, PMID:16408006]. Receptor desensitization is mediated by GRK2 through dual kinase and RGS-for-Gαq/11 mechanisms [PMID:15542600], and HRH1 also couples to Gαi, providing a secondary signaling axis [PMID:40158234]. Beyond classical allergy, HRH1 sensitizes TRPV1 on sensory neurons to drive visceral and endometriosis-associated pain [PMID:26752109, PMID:40600649], promotes glioblastoma cell proliferation via PKC/RAF/MEK/ERK signaling [PMID:41125791], and directs γδT17 cell differentiation through Wnt pathway activation [PMID:41014774]."},"prefetch_data":{"uniprot":{"accession":"P35367","full_name":"Histamine H1 receptor","aliases":[],"length_aa":487,"mass_kda":55.8,"function":"G-protein-coupled receptor for histamine, a biogenic amine that functions as an immune modulator and a neurotransmitter (PubMed:33828102, PubMed:8280179). Through the H1 receptor, histamine mediates the contraction of smooth muscles and increases capillary permeability due to contraction of terminal venules. Also mediates neurotransmission in the central nervous system and thereby regulates circadian rhythms, emotional and locomotor activities as well as cognitive functions (By similarity)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P35367/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HRH1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HRH1","total_profiled":1310},"omim":[{"mim_id":"615475","title":"DExH-BOX HELICASE 34; DHX34","url":"https://www.omim.org/entry/615475"},{"mim_id":"606792","title":"HISTAMINE RECEPTOR H4; HRH4","url":"https://www.omim.org/entry/606792"},{"mim_id":"604525","title":"HISTAMINE RECEPTOR H3; HRH3","url":"https://www.omim.org/entry/604525"},{"mim_id":"603403","title":"DEAH-BOX HELICASE 15; DHX15","url":"https://www.omim.org/entry/603403"},{"mim_id":"600396","title":"DEAH-BOX HELICASE 8; DHX8","url":"https://www.omim.org/entry/600396"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/HRH1"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P35367","domains":[{"cath_id":"1.20.1070.10","chopping":"27-232_401-484","consensus_level":"high","plddt":90.5748,"start":27,"end":484}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P35367","model_url":"https://alphafold.ebi.ac.uk/files/AF-P35367-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P35367-F1-predicted_aligned_error_v6.png","plddt_mean":69.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HRH1","jax_strain_url":"https://www.jax.org/strain/search?query=HRH1"},"sequence":{"accession":"P35367","fasta_url":"https://rest.uniprot.org/uniprotkb/P35367.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P35367/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P35367"}},"corpus_meta":[{"pmid":"8608946","id":"PMC_8608946","title":"A human RNA helicase-like protein, HRH1, facilitates nuclear export of spliced mRNA by releasing the RNA from the spliceosome.","date":"1996","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8608946","citation_count":88,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7935475","id":"PMC_7935475","title":"Identification of a putative RNA helicase (HRH1), a human homolog of yeast Prp22.","date":"1994","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7935475","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15917347","id":"PMC_15917347","title":"Dual role of histamine in modulation of Leydig cell steroidogenesis via HRH1 and HRH2 receptor subtypes.","date":"2005","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/15917347","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29467651","id":"PMC_29467651","title":"Functional G-Protein-Coupled Receptor (GPCR) Synthesis: The Pharmacological Analysis of Human Histamine H1 Receptor (HRH1) Synthesized by a Wheat Germ Cell-Free Protein Synthesis System Combined with Asolectin Glycerosomes.","date":"2018","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29467651","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24236486","id":"PMC_24236486","title":"Variability in histamine receptor genes HRH1, HRH2 and HRH4 in patients with hypersensitivity to NSAIDs.","date":"2013","source":"Pharmacogenomics","url":"https://pubmed.ncbi.nlm.nih.gov/24236486","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31406237","id":"PMC_31406237","title":"Human H1 receptor (HRH1) gene polymorphism is associated with the severity of side effects after desloratadine treatment in Chinese patients with chronic spontaneous uticaria.","date":"2019","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/31406237","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31118923","id":"PMC_31118923","title":"Comparative Genomics of Thiohalobacter thiocyanaticus HRh1T and Guyparkeria sp. SCN-R1, Halophilic Chemolithoautotrophic Sulfur-Oxidizing Gammaproteobacteria Capable of Using Thiocyanate as Energy Source.","date":"2019","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/31118923","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12595443","id":"PMC_12595443","title":"Analysis of the role of Bphs/Hrh1 in the genetic control of responsiveness to pertussis toxin.","date":"2003","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/12595443","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37474883","id":"PMC_37474883","title":"The Roles of Histamine Receptor 1 (hrh1) in Neurotransmitter System Regulation, Behavior, and Neurogenesis in Zebrafish.","date":"2023","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/37474883","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36688618","id":"PMC_36688618","title":"Integrative analysis of small non-coding RNAs predicts a piRNA/miRNA-CCND1/BRAF/HRH1/ATXN3 regulatory circuit that drives oncogenesis in glioblastoma.","date":"2023","source":"Molecular omics","url":"https://pubmed.ncbi.nlm.nih.gov/36688618","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38931172","id":"PMC_38931172","title":"The Anti-Obesogenic Effects of Muscadine Grapes through Ciliary Neurotrophic Factor Receptor (Cntfr) and Histamine Receptor H1 (Hrh1) Genes in 3T3-L1 Differentiated Mouse Cells.","date":"2024","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/38931172","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40600649","id":"PMC_40600649","title":"MRGPRX2 Mediates Mast Cell-Induced Endometriosis Pain Through the Sensitization of Sensory Neurons via Histamine/HRH1/TRPV1 Signaling Pathway.","date":"2025","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/40600649","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41014774","id":"PMC_41014774","title":"Gut microbiota-derived histamine exacerbates psoriasis by promoting γδT17 cell differentiation via the Hrh1/Wnt Axis.","date":"2025","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41014774","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39214333","id":"PMC_39214333","title":"Macrophage Scavenger Receptor 1 attenuates ischemic white matter injury via HRH1-mediated microglial phagocytosis.","date":"2024","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/39214333","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41125791","id":"PMC_41125791","title":"HRH1-targeting mAb: a precision therapeutic strategy for Glioblastoma.","date":"2025","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/41125791","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39037273","id":"PMC_39037273","title":"Identification of HRH1 as an alternative receptor for SARS-CoV-2: insights from viral inhibition by repurposable antihistamines.","date":"2024","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/39037273","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30742585","id":"PMC_30742585","title":"Effect of the Fexofenadine on the expression of HRH-1 and HRH-4 receptor in Peripheral Blood Mononuclear Cell isolated from children with diagnosed allergy - in vitro study Short communication.","date":"2019","source":"Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques","url":"https://pubmed.ncbi.nlm.nih.gov/30742585","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34893496","id":"PMC_34893496","title":"High Expression of Histamine Receptor, HRH1, Reduces Immunotherapy Response.","date":"2021","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/34893496","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41516088","id":"PMC_41516088","title":"The Histamine-Associated Inflammatory Landscape of Endometriosis: Molecular Profiling of HDC, HRH1-HRH4, and Cytokines Across Lesion Subtypes.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41516088","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40158234","id":"PMC_40158234","title":"Sensitive detection of pertussis toxin in acellular pertussis vaccines using HRH1-mediated calcium signaling.","date":"2025","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/40158234","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.07.11.664427","title":"SCOPE: Revealing Hidden Mechanisms in Phenotypic Screens Through Target and Pathway Enrichment","date":"2025-07-14","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.11.664427","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.06.23.661147","title":"Epithelial tumor cells utilize mast cell-derived histamine to regulate perineural invasion","date":"2025-06-27","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.23.661147","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.06.16.659918","title":"Specific GPCRs Elicit Unique Extracellular Vesicle MiRNA Array Signatures: An Exploratory Study","date":"2025-06-20","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.16.659918","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.06.11.659208","title":"Induction of Human Pruriceptors from Pluripotent Stem Cells via Transcription Factors","date":"2025-06-15","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.11.659208","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9311023","id":"PMC_9311023","title":"International Union of Pharmacology. XIII. Classification of histamine receptors.","date":"1997","source":"Pharmacological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/9311023","citation_count":709,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21697825","id":"PMC_21697825","title":"Structure of the human histamine H1 receptor complex with doxepin.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/21697825","citation_count":639,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10973974","id":"PMC_10973974","title":"Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10973974","citation_count":481,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23382691","id":"PMC_23382691","title":"Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23382691","citation_count":292,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26752109","id":"PMC_26752109","title":"Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome.","date":"2016","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/26752109","citation_count":288,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19913121","id":"PMC_19913121","title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19913121","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22169095","id":"PMC_22169095","title":"Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism.","date":"2011","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/22169095","citation_count":143,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18029348","id":"PMC_18029348","title":"Toward a confocal subcellular atlas of the human proteome.","date":"2007","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/18029348","citation_count":114,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8280179","id":"PMC_8280179","title":"Genomic cloning, heterologous expression and pharmacological characterization of a human histamine H1 receptor.","date":"1993","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8280179","citation_count":112,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8003029","id":"PMC_8003029","title":"Molecular cloning of the human histamine H1 receptor gene.","date":"1994","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8003029","citation_count":110,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17627982","id":"PMC_17627982","title":"Histamine excites neurones in the human submucous plexus through activation of H1, H2, H3 and H4 receptors.","date":"2007","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17627982","citation_count":106,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33828102","id":"PMC_33828102","title":"Cryo-EM structure of the human histamine H1 receptor/Gq complex.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33828102","citation_count":96,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18240029","id":"PMC_18240029","title":"Reviews in molecular biology and biotechnology: transmembrane signaling by G protein-coupled receptors.","date":"2008","source":"Molecular biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/18240029","citation_count":92,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11994709","id":"PMC_11994709","title":"Expression and function of histamine receptors in human monocyte-derived dendritic cells.","date":"2002","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11994709","citation_count":91,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19156168","id":"PMC_19156168","title":"Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis.","date":"2009","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/19156168","citation_count":84,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16888049","id":"PMC_16888049","title":"H1 and H2 receptors mediate postexercise hyperemia in sedentary and endurance exercise-trained men and women.","date":"2006","source":"Journal of applied physiology (Bethesda, Md. : 1985)","url":"https://pubmed.ncbi.nlm.nih.gov/16888049","citation_count":78,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16408006","id":"PMC_16408006","title":"Linking agonist binding to histamine H1 receptor activation.","date":"2005","source":"Nature chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/16408006","citation_count":77,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19193342","id":"PMC_19193342","title":"Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.","date":"2008","source":"The Journal of clinical psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19193342","citation_count":75,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15542600","id":"PMC_15542600","title":"Bimodal regulation of the human H1 histamine receptor by G protein-coupled receptor kinase 2.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15542600","citation_count":72,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18577758","id":"PMC_18577758","title":"Dissociation of heterotrimeric g proteins in cells.","date":"2008","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/18577758","citation_count":69,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20237496","id":"PMC_20237496","title":"New genetic associations detected in a host response study to hepatitis B vaccine.","date":"2010","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/20237496","citation_count":69,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16754659","id":"PMC_16754659","title":"Stable association between G alpha(q) and phospholipase C beta 1 in living cells.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16754659","citation_count":65,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22860191","id":"PMC_22860191","title":"Role of histamine and its receptors in cerebral ischemia.","date":"2012","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22860191","citation_count":58,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28298427","id":"PMC_28298427","title":"Systematic protein-protein interaction mapping for clinically relevant human GPCRs.","date":"2017","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/28298427","citation_count":58,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15342556","id":"PMC_15342556","title":"Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15342556","citation_count":57,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11898002","id":"PMC_11898002","title":"Expression and function of histamine receptors 1 and 2 on human monocyte-derived dendritic cells.","date":"2002","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11898002","citation_count":54,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":13079,"output_tokens":3493,"usd":0.045816},"stage2":{"model":"claude-opus-4-6","input_tokens":6912,"output_tokens":2265,"usd":0.136777},"total_usd":0.420082,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":27311,"output_tokens":5201,"usd":0.079974},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":8982,"output_tokens":2404,"usd":0.157515}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"HRH1 (human RNA helicase 1) was identified as a functional human homolog of yeast Prp22, a DEAH-box RNA helicase involved in pre-mRNA splicing. HRH1 expression partially rescued the temperature-sensitive phenotype of a yeast prp22 mutant. HRH1 contains an RS domain absent in Prp22 that mediates interaction with SR protein family members in vitro and in the yeast two-hybrid system, suggesting it is targeted to the spliceosome through this interaction.\",\n      \"method\": \"Yeast complementation assay, in vitro binding, yeast two-hybrid\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — functional rescue in yeast plus two orthogonal binding assays in a single study; replicated in follow-up paper\",\n      \"pmids\": [\"7935475\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"HRH1 facilitates nuclear export of spliced mRNA by releasing spliced RNA from the spliceosome. Dominant-negative HRH1++ mutants stall on the spliceosome and block release of spliced RNA in vitro. Expression of dominant-negative HRH1 in mammalian cells inhibits splicing and causes nuclear export of unspliced pre-mRNA, likely because spliceosome recycling is prevented. The RS domain of HRH1 confers nuclear localization and facilitates interaction with the spliceosome.\",\n      \"method\": \"Dominant-negative mutant expression in vitro and in mammalian cells, subcellular localization, in vitro splicing assay\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro biochemical assay with dominant-negative mutagenesis plus cellular phenotype readout; foundational paper with 88 citations\",\n      \"pmids\": [\"8608946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HRH1 (histamine H1 receptor) in Leydig cells couples to Gq protein and activates phospholipase C, leading to increased inositol phosphate production. HRH1 activation mediates inhibition of steroidogenesis in MA-10 murine and purified rat Leydig cells, as demonstrated with selective HRH1 agonists and antagonists.\",\n      \"method\": \"Pharmacological dissection with selective agonists/antagonists, inositol phosphate assay\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean pharmacological dissection with multiple selective agents; single lab\",\n      \"pmids\": [\"15917347\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Bphs/Hrh1 (histamine H1 receptor) was identified as the locus controlling pertussis toxin (PTX)-induced hypersensitivity to histamine. Using Bphs congenic mice and Hrh1 knockout mice, Hrh1 was shown to be specifically required for histamine hypersensitivity and enhancement of antigen-specific delayed-type hypersensitivity after PTX intoxication, but not for other PTX-induced phenotypes (leukocytosis, lethality, glucose regulation, serotonin hypersensitivity).\",\n      \"method\": \"Genetic knockout, congenic mouse strains, in vivo PTX challenge with defined phenotypic readouts\",\n      \"journal\": \"Infection and immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with specific and controlled phenotypic readouts distinguishing Hrh1-dependent from -independent PTX effects\",\n      \"pmids\": [\"12595443\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The Asp107 residue of human HRH1 is critical for high-affinity binding of H1 antagonists (e.g., [3H]pyrilamine). D107A mutant HRH1 synthesized in a cell-free system showed markedly reduced and non-saturable radioligand binding compared to wild-type, demonstrating the role of Asp107 in antagonist binding.\",\n      \"method\": \"Cell-free protein synthesis, radioligand binding assay, site-directed mutagenesis (D107A)\",\n      \"journal\": \"Frontiers in pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis; single lab, single study\",\n      \"pmids\": [\"29467651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HRH1 (histamine H1 receptor) functions as an alternative receptor for SARS-CoV-2 via direct binding to viral spike proteins, enabling hACE2-independent infection. Antihistamine drugs targeting HRH1 potently inhibit SARS-CoV-2 entry.\",\n      \"method\": \"Direct binding assay (spike protein-HRH1 interaction), viral entry inhibition assay\",\n      \"journal\": \"mBio\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding and functional entry inhibition; cited as published findings from referenced study (Yu et al.)\",\n      \"pmids\": [\"39037273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"MSR1 overexpression increases Akt phosphorylation via HRH1, promoting microglial phagocytosis of myelin debris through the PI3K/AKT pathway and mitigating ischemic white matter injury. MSR1-deficient mice showed exacerbated white matter injury, and Msr1 overexpression accelerated myelin debris clearance in an HRH1-dependent manner.\",\n      \"method\": \"Msr1 knockout mice, Msr1 overexpression, immunoblotting for pAkt, behavioral assays\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — mechanistic link between MSR1, HRH1, and PI3K/AKT supported by OE/KO with limited direct HRH1 mechanistic validation\",\n      \"pmids\": [\"39214333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HRH1 (histamine H1 receptor) activates both Gαq and Gαi heterotrimers as demonstrated by mini G protein recruitment and Gα activation assays. Pertussis toxin disrupts histamine-induced Gαi binding to HRH1, causing a compensatory increase in Gαq binding and enhanced calcium signaling.\",\n      \"method\": \"Mini G protein recruitment assay, Gα activation assay, calcium signaling assay in MDA-MB-231 cells\",\n      \"journal\": \"Vaccine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct biochemical G-protein coupling assays with multiple orthogonal methods; single lab\",\n      \"pmids\": [\"40158234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HRH1 mediates sensory neuron sensitization in endometriosis pain through the histamine/HRH1/TRPV1 signaling pathway. MRGPRX2 activation on mast cells by HBD-2 from endometriotic cells triggers histamine release; histamine increases Ca2+ influx in DRG cells via HRH1, and desloratadine (H1 antagonist) reverses this process.\",\n      \"method\": \"Mast cell MRGPRX2 KO, Ca2+ imaging in DRG cells, pharmacological inhibition with desloratadine, endometriosis mouse model\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway defined by KO, pharmacological inhibition, and Ca2+ imaging; single study\",\n      \"pmids\": [\"40600649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HRH1 activation by gut microbiota-derived histamine promotes γδT17 cell differentiation through Hrh1 receptor-dependent activation of the Wnt signaling pathway, exacerbating psoriatic skin inflammation. RNA sequencing showed histamine exposure upregulated Hrh1 and Wnt pathway genes; in vitro experiments confirmed γδT17 differentiation in an Hrh1-dependent manner.\",\n      \"method\": \"RNA sequencing, pathway enrichment, in vitro differentiation assays, histamine-producing E. coli colonization model, γδT cell-deficient mice\",\n      \"journal\": \"International immunopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic link supported by transcriptomics, in vitro functional assays, and in vivo genetic models; single lab\",\n      \"pmids\": [\"41014774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Genetic silencing of HRH1 inhibits GBM cell proliferation, migration, and invasion. Mechanistic studies revealed that HRH1-targeting mAb and the antagonist terfenadine exert anti-tumor effects via PKC-dependent regulation of the RAF/MEK/ERK signaling pathway.\",\n      \"method\": \"Genetic silencing (shRNA/siRNA), mAb treatment, in vitro proliferation/migration/invasion assays, in vivo xenograft, signaling pathway analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with defined signaling pathway readout; single lab study\",\n      \"pmids\": [\"41125791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In zebrafish, hrh1 knockout (CRISPR/Cas9) during early development caused reduced tyrosine hydroxylase 1 (Th1)-positive dopaminergic cells, reduced hcrt (hypocretin)-positive cells, and transient abnormal expression of neurodevelopmental markers, demonstrating HRH1 is required for normal dopaminergic and hypocretinergic system development. Adult hrh1-/- fish showed impaired sociability, anxious-like behavior, and downregulation of choline acetyltransferase a and Islet1.\",\n      \"method\": \"CRISPR/Cas9 knockout, immunocytochemistry, in situ hybridization, qPCR, behavioral assays\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with multiple orthogonal cellular and behavioral readouts; zebrafish ortholog\",\n      \"pmids\": [\"37474883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HRH1 regulates exodosis (ER-stress induced secretion of ER-resident proteins) through calcium signaling. RNAi knockdown and pharmacological inhibition of HRH1 validated its role in modulating this process, implicating HRH1 as part of Gq-coupled IP3R-mediated calcium signaling in ER stress responses.\",\n      \"method\": \"High-throughput screen, RNAi knockdown, pharmacological inhibition, SCOPE pathway enrichment analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — validated by RNAi and pharmacology but mechanistic depth is limited; preprint, single lab\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HRH1 on tumor cells mediates histamine-driven perineural invasion through P38 activation and broad upregulation of matrix metalloproteinases (MMPs), enabling collagen degradation in the nerve sheath. H1-antihistamines rescued histamine-enhanced tumor invasion into nerve in PNI organoids.\",\n      \"method\": \"Single-cell transcriptomics, PNI organoid model, pharmacological rescue with H1-antihistamines, MMP expression analysis, P38 signaling analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — mechanistic pathway proposed with organoid rescue and signaling data; preprint, single lab\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"HRH1 encodes two distinct proteins that share the gene symbol: (1) a DEAH-box RNA helicase (human Prp22 homolog) that releases spliced mRNA from the spliceosome to facilitate nuclear export, targeting the spliceosome via its unique RS domain that interacts with SR proteins; and (2) the histamine H1 receptor, a Gq/Gi-coupled GPCR whose activation by histamine triggers inositol phosphate production and calcium signaling, mediates neuronal sensitization via the HRH1/TRPV1 axis, drives γδT17 differentiation via Wnt signaling, regulates tumor cell invasion through P38/MMP activation, and modulates RAF/MEK/ERK signaling in glioblastoma, with Asp107 being critical for antagonist binding.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"HRH1 (human RNA helicase 1) was identified as a human homolog of yeast Prp22, containing DEAH-box helicase motifs. HRH1 expression in a S. cerevisiae prp22 mutant partially rescued its temperature-sensitive phenotype. HRH1 contains an RS domain absent in Prp22, and this RS domain mediates interaction with SR protein family members both in vitro and in the yeast two-hybrid system, suggesting HRH1 is targeted to the spliceosome through this interaction.\",\n      \"method\": \"PCR cloning, yeast complementation assay, in vitro interaction assay, yeast two-hybrid\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including functional complementation and direct interaction assays\",\n      \"pmids\": [\"7935475\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"HRH1 facilitates nuclear export of spliced mRNA by releasing it from the spliceosome. Dominant-negative HRH1++ mutants (dn-HRH1) stall on the spliceosome and prevent release of spliced RNA from the spliceosome in vitro. Expression of dn-HRH1 in mammalian cells inhibits splicing and causes nuclear export of unspliced pre-mRNA due to spliceosome recycling defects. The RS domain of HRH1 confers a nuclear localization signal and facilitates interaction with the spliceosome.\",\n      \"method\": \"Dominant-negative mutant expression, in vitro spliceosome release assay, mammalian cell transfection\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — dominant-negative in vitro and in vivo assays with defined molecular phenotype, replicated across systems\",\n      \"pmids\": [\"8608946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The human histamine H1 receptor (HRH1/H1R) was cloned from a human genomic library; the 487-amino acid protein is a G-protein-coupled receptor. When expressed in COS-7 cells, it shows saturable binding of [3H]pyrilamine (KD ~1.2 nM) and mediates histamine-induced inositol phosphate formation that is inhibitable by pyrilamine, demonstrating coupling to the Gq/phospholipase C pathway.\",\n      \"method\": \"Genomic cloning, heterologous expression in COS-7 cells, radioligand binding assay, inositol phosphate formation assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution of receptor in heterologous system with functional assays confirming Gq coupling\",\n      \"pmids\": [\"8280179\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The human histamine H1 receptor gene is intron-lacking, encodes a 487-amino acid protein with GTP-binding protein-coupled receptor characteristics, and is mapped to chromosome 3p25 by fluorescence in situ hybridization. Northern blot analysis revealed tissue-specific expression with two mRNA species (3.0 and 3.5 kb) in peripheral tissues and only the 3.5-kb species in brain.\",\n      \"method\": \"Genomic cloning, Northern blot, FISH chromosomal mapping\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct experimental chromosomal mapping and tissue expression confirmed by multiple methods\",\n      \"pmids\": [\"8003029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GRK2 is the principal kinase mediating H1 histamine receptor (H1HR) desensitization in HEK293 cells. GRK2 overexpression promotes H1HR phosphorylation and completely inhibits inositol phosphate production. GRK2 regulates H1HR signaling through dual mechanisms: its kinase activity and its RGS function for Gαq/11. siRNA knockdown of endogenous GRK2 significantly increased histamine-promoted calcium flux, confirming endogenous GRK2 role. GRK5 had no significant effect.\",\n      \"method\": \"Overexpression of wild-type and mutant GRKs in HEK293 cells, phosphorylation assay, inositol phosphate assay, siRNA knockdown, calcium flux assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including mutagenesis and siRNA knockdown with defined molecular mechanism\",\n      \"pmids\": [\"15542600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Using site-directed mutagenesis and molecular modeling, Ser3.36 and Asn7.45 were identified as key residues linking histamine binding to receptor activation in the human histamine H1 receptor. Ser3.36 acts as a rotamer toggle switch that upon agonist binding initiates receptor activation through Asn7.45, involving conformational changes in helices 6 and 7.\",\n      \"method\": \"Site-directed mutagenesis, molecular modeling\",\n      \"journal\": \"Nature chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with functional validation defining activation mechanism\",\n      \"pmids\": [\"16408006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Crystal structure of the human histamine H1 receptor in complex with the first-generation antagonist doxepin was determined. Doxepin sits deep in the ligand-binding pocket and directly interacts with Trp428(6.48), a key residue in GPCR activation. The pocket has mostly hydrophobic character explaining low selectivity of first-generation compounds. Second-generation antagonists interact with Lys191(5.39) and/or Lys179(ECL2) in an anion-binding region not conserved in other aminergic receptors, explaining their selectivity.\",\n      \"method\": \"X-ray crystallography, molecular docking\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with docking analysis revealing molecular basis of ligand selectivity\",\n      \"pmids\": [\"21697825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HRH1 (histamine H1 receptor) activation in MA-10 murine and purified rat Leydig cells mediates inhibition of steroid synthesis. HRH1 activation increases inositol phosphate production, consistent with coupling to Gq protein and phospholipase C, while HRH2 activation stimulates steroidogenesis via adenylate cyclase/Gs. Selective agonists and antagonists confirmed these distinct receptor-pathway couplings.\",\n      \"method\": \"Pharmacological assay with selective agonists/antagonists, inositol phosphate assay, cAMP assay in Leydig cells\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological dissection with selective ligands, single study\",\n      \"pmids\": [\"15917347\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"HRH1-mediated sensitization of TRPV1 is involved in visceral hypersensitivity in irritable bowel syndrome. Supernatants from IBS rectal biopsies sensitized TRPV1 in mouse dorsal root ganglion neurons via HRH1; histamine and imidazole acetaldehyde reproduced this effect. Pyrilamine (HRH1 antagonist) blocked histamine-induced TRPV1 sensitization. The HRH1 antagonist ebastine reduced visceral hypersensitivity in a randomized placebo-controlled clinical trial.\",\n      \"method\": \"Live calcium imaging of submucosal neurons, mouse DRG neuron sensitization assay, pharmacological blockade, randomized controlled trial\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal experimental approaches plus clinical validation; replicated across systems\",\n      \"pmids\": [\"26752109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Cryo-EM structure of the human histamine H1 receptor in complex with Gq protein in active conformation was determined. Histamine activates the receptor by interacting with key residues in TM3 and TM6, squashing the binding pocket on the extracellular side and opening a cavity on the intracellular side for Gq engagement. ICL2 of H1R interacts with the αN-β junction of Gq/11 protein.\",\n      \"method\": \"Cryo-electron microscopy, NanoBiT tethering strategy\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM structure revealing activation mechanism and Gq coupling interface\",\n      \"pmids\": [\"33828102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Wild-type HRH1 synthesized in a wheat germ cell-free system with glycerosomes exhibited saturable binding to [3H]pyrilamine (Kd = 9.76 nM). A D107A mutant HRH1 (Asp107 replaced by Ala) showed markedly reduced and non-saturable binding to the H1 antagonist, confirming that Asp107 is critical for ligand binding.\",\n      \"method\": \"Cell-free protein synthesis, radioligand binding assay, mutant receptor analysis\",\n      \"journal\": \"Frontiers in pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with mutagenesis confirming critical residue, single study\",\n      \"pmids\": [\"29467651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HRH1 activates both Gαq and Gαi heterotrimers as shown by mini G protein recruitment and Gα activation assays in MDA-MB-231 cells. Pertussis toxin (PTx) disrupts histamine-induced Gαi binding to HRH1, causing a compensatory increase in Gαq binding and enhanced calcium signaling, which enables sensitive detection of PTx activity.\",\n      \"method\": \"Mini G protein recruitment assay, Gα activation assay, calcium signaling assay\",\n      \"journal\": \"Vaccine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct G protein coupling assays demonstrating dual Gαq/Gαi signaling, single study\",\n      \"pmids\": [\"40158234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Systematic membrane yeast two-hybrid (MYTH) mapping identified protein-protein interaction partners for human HRH1 among 686 proteins connected through 987 unique interactions across 48 GPCRs, providing a resource for HRH1 signaling pathway analysis.\",\n      \"method\": \"Membrane yeast two-hybrid (MYTH) interactome mapping\",\n      \"journal\": \"Molecular systems biology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — large-scale Y2H mapping, HRH1-specific interactions not individually validated\",\n      \"pmids\": [\"28298427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In glioblastoma, genetic silencing of HRH1 inhibited GBM cell proliferation, migration, and invasion in vitro and in vivo. The HRH1-targeting monoclonal antibody and the specific antagonist terfenadine exerted anti-tumor effects mechanistically through PKC-dependent regulation of the RAF/MEK/ERK signaling pathway.\",\n      \"method\": \"siRNA/shRNA knockdown, xenograft model, pharmacological antagonism with terfenadine, signaling pathway analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacological loss-of-function with identified downstream signaling mechanism, single study\",\n      \"pmids\": [\"41125791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"MSR1 overexpression in microglia increases phosphorylation of Akt via HRH1, expediting clearance of myelin debris through the PI3K/AKT pathway in ischemic white matter injury. MSR1-deficient mice showed exacerbated behavioral deficits and white matter injury after ischemic stroke.\",\n      \"method\": \"Gene knockout mouse model, overexpression studies, ischemic stroke model, pathway analysis\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO and overexpression with defined signaling mechanism, single study\",\n      \"pmids\": [\"39214333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Histamine promotes γδT17 cell differentiation through HRH1 in an Hrh1 receptor-dependent manner, with associated Wnt signaling pathway activation. RNA sequencing showed histamine exposure upregulated Hrh1 and activated the Wnt pathway, and in vitro experiments confirmed HRH1 dependence of this process.\",\n      \"method\": \"RNA sequencing, in vitro cell differentiation assay, pharmacological receptor blockade, pathway analysis\",\n      \"journal\": \"International immunopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — receptor-dependent functional assay with transcriptomic validation, single study\",\n      \"pmids\": [\"41014774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Bphs/Hrh1 (histamine H1 receptor) controls susceptibility to pertussis toxin-induced histamine hypersensitivity and enhancement of antigen-specific delayed-type hypersensitivity responses. Using Bphs congenic and Hrh1 gene-disrupted mice, Hrh1 was shown to specifically mediate vasoactive amine sensitization to histamine but not serotonin, and did not influence lethal effects, leukocytosis, glucose regulation, or histamine-independent vascular permeability changes.\",\n      \"method\": \"Congenic mouse model, Hrh1 knockout mice, in vivo pertussis toxin challenge\",\n      \"journal\": \"Infection and immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with defined phenotypic specificity, single study\",\n      \"pmids\": [\"12595443\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In zebrafish, CRISPR/Cas9-generated hrh1-/- larvae showed transiently reduced tyrosine hydroxylase 1 (Th1)-positive (dopaminergic) cells and hypocretin-positive cells during early development, indicating HRH1 regulates dopaminergic and hypocretin/orexin systems. Adult hrh1-/- fish displayed impaired sociability and anxious-like behavior with downregulation of choline O-acetyltransferase a and LIM homeodomain transcription factor Islet1, suggesting HRH1 involvement in cholinergic and developmental gene regulation.\",\n      \"method\": \"CRISPR/Cas9 knockout, qPCR, in situ hybridization, immunocytochemistry, behavioral assays\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with defined neurodevelopmental phenotypes and molecular markers, single study\",\n      \"pmids\": [\"37474883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MRGPRX2 activation on mast cells by HBD-2 (secreted from endometriotic cells) triggers histamine release, which sensitizes dorsal root ganglion sensory neurons via HRH1/TRPV1 signaling to produce endometriosis pain. Desloratadine (HRH1 antagonist) reversed histamine-induced Ca2+ influx in DRG cells. Mrgprb2-deficient mice showed reduced hyperalgesia and lesion size.\",\n      \"method\": \"In vitro mast cell culture, Ca2+ imaging in DRG neurons, pharmacological antagonism, Mrgprb2 KO mouse model\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological and genetic loss-of-function establishing HRH1/TRPV1 signaling axis, single study\",\n      \"pmids\": [\"40600649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Phenotypic screening and SCOPE computational enrichment identified HRH1 as a regulator of ER stress-induced exodosis (secretion of ER-resident proteins). This was validated by RNAi knockdown and pharmacological inhibition of HRH1, implicating HRH1-mediated calcium signaling (via Gq/IP3R pathway) in regulation of exodosis.\",\n      \"method\": \"High-throughput phenotypic screen, SCOPE pathway enrichment, RNAi knockdown, pharmacological inhibition\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — computational enrichment with RNAi/pharmacological validation, preprint, single study\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In cutaneous squamous cell carcinoma with perineural invasion, tumor cells express elevated HRH1, and histamine from mast cells enhances tumor invasion into nerves via broad upregulation of matrix metalloproteinases (MMPs) through P38 activation, enabling collagen degradation in the nerve sheath. H1-antihistamines rescued this effect in PNI organoid models.\",\n      \"method\": \"Single-cell transcriptomics, PNI organoid model, pharmacological H1 blockade, MMP/P38 pathway analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — organoid model with pharmacological validation and mechanistic pathway identification, preprint\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"HRH1 encodes two distinct proteins: (1) the canonical histamine H1 receptor, a 487-amino acid GPCR (chromosome 3p25) that couples primarily to Gq/11 to activate phospholipase C/inositol phosphate signaling and Ca2+ release, is desensitized by GRK2 through both kinase and RGS mechanisms, and whose crystal and cryo-EM structures reveal that histamine binding at TM3/TM6 (via Ser3.36/Asn7.45 rotamer switching) squashes the extracellular pocket and opens the intracellular cavity for Gq engagement—mediating allergy, visceral hypersensitivity via TRPV1 sensitization, endometriosis pain, GBM proliferation via PKC/RAF/MEK/ERK, and immune cell functions; and (2) an unrelated nuclear RNA helicase (DEAH-box protein, human Prp22 homolog) that uses its helicase activity to release spliced mRNA from the spliceosome and whose RS domain confers nuclear localization and spliceosome targeting through interaction with SR proteins.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HRH1 (histamine H1 receptor) is a Gq/Gi-coupled GPCR that transduces histamine signaling into diverse cellular responses including calcium mobilization, inositol phosphate production, and activation of downstream kinase cascades. Histamine binding activates both Gαq and Gαi heterotrimers, with pertussis toxin disruption of Gαi coupling causing compensatory Gαq enhancement and increased calcium signaling [PMID:40158234]; Gq-mediated phospholipase C activation drives inositol phosphate accumulation in responsive cell types [PMID:15917347]. HRH1 signaling engages context-dependent effector pathways: the HRH1/TRPV1 axis mediates sensory neuron sensitization and calcium influx in dorsal root ganglia [PMID:40600649], Wnt pathway activation downstream of HRH1 drives γδT17 cell differentiation in psoriatic inflammation [PMID:41014774], and PKC-dependent RAF/MEK/ERK signaling sustains glioblastoma cell proliferation and invasion [PMID:41125791]. HRH1 is required in vivo for pertussis toxin-induced histamine hypersensitivity and delayed-type hypersensitivity responses [PMID:12595443], and zebrafish hrh1 knockout demonstrates a developmental requirement for dopaminergic and hypocretinergic neuron specification [PMID:37474883].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Genetic evidence established that Hrh1 is the specific receptor required for pertussis toxin-induced histamine hypersensitivity and enhancement of delayed-type hypersensitivity, resolving the identity of the Bphs locus and distinguishing HRH1-dependent from HRH1-independent PTX effects.\",\n      \"evidence\": \"Hrh1 knockout mice and Bphs congenic strains challenged with pertussis toxin in vivo\",\n      \"pmids\": [\"12595443\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Downstream signaling mechanism linking HRH1 to PTX-enhanced immune sensitization was not defined\",\n        \"Whether HRH1 acts on immune cells directly or indirectly through vascular/neuronal effects was not resolved\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Pharmacological dissection demonstrated that HRH1 couples to Gq to activate phospholipase C and inositol phosphate production, establishing the canonical Gq signaling pathway for HRH1 in a steroidogenic cell context.\",\n      \"evidence\": \"Selective HRH1 agonists/antagonists with inositol phosphate assays in MA-10 and rat Leydig cells\",\n      \"pmids\": [\"15917347\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether HRH1 couples to additional G proteins beyond Gq was not tested\",\n        \"The downstream mechanism by which HRH1 inhibits steroidogenesis was not fully elucidated\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Site-directed mutagenesis identified Asp107 as critical for high-affinity antagonist binding, providing structural insight into the HRH1 ligand-binding pocket.\",\n      \"evidence\": \"D107A mutant HRH1 synthesized cell-free, radioligand binding with [³H]pyrilamine\",\n      \"pmids\": [\"29467651\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No full structural model of the HRH1 binding pocket was provided\",\n        \"Contribution of Asp107 to agonist vs. antagonist binding selectivity was not resolved\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"HRH1 was identified as an alternative receptor for SARS-CoV-2 spike protein enabling hACE2-independent viral entry, expanding the known functions of HRH1 beyond histamine signaling.\",\n      \"evidence\": \"Direct spike protein-HRH1 binding assay and viral entry inhibition with antihistamines\",\n      \"pmids\": [\"39037273\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Physiological relevance of HRH1-mediated SARS-CoV-2 entry relative to ACE2-mediated entry not quantified in vivo\",\n        \"Structural basis for spike-HRH1 interaction not determined\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"CRISPR knockout of hrh1 in zebrafish revealed a developmental requirement for dopaminergic and hypocretinergic neuron specification, linking HRH1 to neurodevelopmental programs beyond classical histamine signaling.\",\n      \"evidence\": \"CRISPR/Cas9 hrh1 KO zebrafish with immunocytochemistry, ISH, behavioral assays\",\n      \"pmids\": [\"37474883\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether the neurodevelopmental role is cell-autonomous or mediated through circuit-level histamine signaling was not resolved\",\n        \"Mammalian validation of the neurodevelopmental phenotype is lacking\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Biochemical G protein coupling assays demonstrated that HRH1 activates both Gαq and Gαi heterotrimers, and that PTX-mediated Gαi disruption causes compensatory Gαq activation and enhanced calcium signaling — resolving the dual G protein coupling of HRH1.\",\n      \"evidence\": \"Mini G protein recruitment assay, Gα activation assay, calcium signaling in MDA-MB-231 cells\",\n      \"pmids\": [\"40158234\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Relative stoichiometry and kinetics of Gαq vs. Gαi coupling under physiological conditions not established\",\n        \"Whether Gαi coupling has distinct downstream effectors from Gαq in HRH1 signaling was not explored\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Multiple studies defined context-dependent HRH1 effector pathways: HRH1/TRPV1 axis for sensory neuron Ca²⁺ influx in endometriosis pain, Wnt pathway activation for γδT17 differentiation in psoriasis, and PKC/RAF/MEK/ERK for glioblastoma proliferation and invasion.\",\n      \"evidence\": \"Ca²⁺ imaging with HRH1 pharmacology in DRG neurons; RNA-seq and in vitro differentiation assays for γδT cells; shRNA silencing with kinase pathway analysis in GBM xenografts\",\n      \"pmids\": [\"40600649\", \"41014774\", \"41125791\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"How a single GPCR activates such divergent pathways (Wnt, TRPV1, RAF/MEK/ERK) in different cell types is not mechanistically explained\",\n        \"Whether these context-dependent pathways share a common proximal signaling node downstream of HRH1 is unknown\",\n        \"Independent replication in each disease context has not been reported\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis for HRH1's dual Gαq/Gαi coupling, the determinants of cell-type-specific effector pathway selection, and the mechanism by which HRH1 contributes to neurodevelopment remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No high-resolution structure of active HRH1 bound to G proteins has been reported in the timeline\",\n        \"Cell-type determinants of pathway selection (Wnt vs. TRPV1 vs. RAF/MEK/ERK) are undefined\",\n        \"Mammalian genetic models for the neurodevelopmental role of HRH1 are absent\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [2, 3, 7, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 4, 5, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 7, 8, 9, 10]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 9]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"TRPV1\",\n      \"GNA11\",\n      \"GNAI1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"The histamine H1 receptor (HRH1) is a Gq/11-coupled GPCR that activates phospholipase C to generate inositol phosphates and mobilize intracellular calcium, mediating allergic, inflammatory, and neuromodulatory responses to histamine [PMID:8280179, PMID:15542600]. Crystal and cryo-EM structures reveal that histamine binding deep in the transmembrane pocket engages a Ser3.36/Asn7.45 rotamer switch that compresses the extracellular face and opens the intracellular cavity for Gq engagement via the ICL2–Gαq αN-β junction interface [PMID:21697825, PMID:33828102, PMID:16408006]. Receptor desensitization is mediated by GRK2 through dual kinase and RGS-for-Gαq/11 mechanisms [PMID:15542600], and HRH1 also couples to Gαi, providing a secondary signaling axis [PMID:40158234]. Beyond classical allergy, HRH1 sensitizes TRPV1 on sensory neurons to drive visceral and endometriosis-associated pain [PMID:26752109, PMID:40600649], promotes glioblastoma cell proliferation via PKC/RAF/MEK/ERK signaling [PMID:41125791], and directs γδT17 cell differentiation through Wnt pathway activation [PMID:41014774].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Cloning and heterologous expression of the human histamine H1 receptor established it as a Gq-coupled GPCR that mediates inositol phosphate formation, resolving the molecular identity of the pharmacologically defined H1 receptor.\",\n      \"evidence\": \"Genomic cloning with radioligand binding and IP formation assays in COS-7 cells\",\n      \"pmids\": [\"8280179\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream effectors beyond PLC not characterized\", \"No structural information on the receptor\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Chromosomal mapping to 3p25 and demonstration of an intronless gene with tissue-specific mRNA isoforms defined the genomic architecture of HRH1.\",\n      \"evidence\": \"FISH mapping and Northern blot analysis\",\n      \"pmids\": [\"8003029\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional significance of two mRNA species unresolved\", \"Promoter regulation not characterized\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identification of GRK2 as the principal desensitization kinase for HRH1, operating through both phosphorylation and an RGS-like mechanism toward Gαq/11, explained how H1 receptor signaling is terminated.\",\n      \"evidence\": \"GRK overexpression/mutagenesis, siRNA knockdown, and calcium flux assays in HEK293 cells\",\n      \"pmids\": [\"15542600\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Arrestin recruitment and internalization trafficking not defined\", \"In vivo desensitization kinetics unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Mutagenesis of Ser3.36 and Asn7.45 revealed a rotamer toggle switch linking agonist binding to conformational activation, providing the first mechanistic model of H1R activation at atomic resolution.\",\n      \"evidence\": \"Site-directed mutagenesis with functional assays and molecular modeling\",\n      \"pmids\": [\"16408006\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No experimental structure available at that time\", \"Contributions of other residues to activation not mapped\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"The crystal structure of H1R bound to doxepin revealed the molecular basis of first- versus second-generation antihistamine selectivity, showing that selective compounds exploit a non-conserved anion-binding region involving Lys191/Lys179.\",\n      \"evidence\": \"X-ray crystallography with molecular docking\",\n      \"pmids\": [\"21697825\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Active-state structure not yet available\", \"Gq coupling interface not resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstration that HRH1 sensitizes TRPV1 on sensory neurons extended the receptor's role beyond allergy into visceral pain pathophysiology, validated by clinical efficacy of the H1 antagonist ebastine in IBS.\",\n      \"evidence\": \"DRG neuron calcium imaging, pharmacological blockade, and randomized controlled trial\",\n      \"pmids\": [\"26752109\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Intracellular signaling intermediates linking HRH1 to TRPV1 sensitization not fully mapped\", \"Long-term clinical efficacy data limited\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"The cryo-EM structure of the active H1R–Gq complex revealed that histamine compresses the extracellular pocket while opening an intracellular cavity, and that ICL2 contacts the αN-β junction of Gq, completing the structural picture of receptor activation and G protein engagement.\",\n      \"evidence\": \"Cryo-EM with NanoBiT tethering strategy\",\n      \"pmids\": [\"33828102\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biased agonism and alternative G protein coupling structural basis not resolved\", \"No structure of β-arrestin-bound H1R\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Functional studies established that HRH1 couples to both Gαq and Gαi, with pertussis toxin-mediated disruption of Gαi causing compensatory enhancement of Gαq signaling, revealing dual G protein engagement.\",\n      \"evidence\": \"Mini G protein recruitment and Gα activation assays in MDA-MB-231 cells\",\n      \"pmids\": [\"40158234\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological contexts where Gαi coupling predominates not defined\", \"Structural basis for dual coupling unknown\", \"Independent replication in other cell lines needed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"In glioblastoma, HRH1 was shown to drive proliferation, migration, and invasion through PKC-dependent RAF/MEK/ERK activation, establishing oncogenic signaling downstream of H1R in brain tumors.\",\n      \"evidence\": \"siRNA/shRNA knockdown, xenograft models, and terfenadine antagonism with signaling pathway analysis\",\n      \"pmids\": [\"41125791\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether constitutive activity or autocrine histamine drives GBM signaling unclear\", \"Patient-derived data on HRH1 expression and outcomes limited\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"HRH1/TRPV1 signaling was extended to endometriosis pain, with mast cell-derived histamine sensitizing DRG neurons through HRH1, broadening the receptor's pain-related roles beyond IBS.\",\n      \"evidence\": \"Ca2+ imaging in DRG neurons, desloratadine blockade, Mrgprb2 KO mouse model\",\n      \"pmids\": [\"40600649\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream kinase pathway from HRH1 to TRPV1 phosphorylation not identified\", \"Clinical translation to endometriosis patients not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of biased agonism and β-arrestin engagement at H1R, the full spectrum of tissues where Gαi coupling is physiologically relevant, and whether constitutive H1R activity contributes to tumor signaling independently of histamine.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No β-arrestin-bound H1R structure\", \"In vivo biased signaling not characterized\", \"Role of constitutive activity in cancer not delineated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [2, 5, 9]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [4, 8, 15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 6, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 4, 5, 9, 11]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [15, 16]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [8, 17, 18]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"GRK2\",\n      \"GNAQ\",\n      \"GNA11\",\n      \"GNAI1\",\n      \"TRPV1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}